---
figid: PMC5592089__nihms902445f1
figtitle: PI3K/AKT/mTOR pathway and interaction with PTEN and TSC1/TSC2
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
pmcid: PMC5592089
filename: nihms902445f1.jpg
figlink: /pmc/articles/PMC5592089/figure/F1/
number: F1
caption: 'Diagram of the PI3K/AKT/mTOR pathway and interaction with PTEN and TSC1/TSC2.
  Potential sites of action of inhibitors are shown. PI3K converts PIP2 into PIP3,
  which interacts with AKT at the cellular membrane where it is phosphorylated and
  activated. PTEN is a negative regulator of PI3K, which dephosphorylates PIP3. AKT
  serves a range of cellular functions with effects on metabolism and cell survival,
  and through indirect activation of mTOR controls cell proliferation, protein translation,
  and autophagy. mTOR exists as two multi-protein complexes, mTORC1 and mTORC2. mTORC2
  lies upstream of and activates AKT, whereas mTORC1 lies downstream from AKT and
  is activated via AKT-mediated inhibition of tuberous sclerosis complex 1 and 2 (TSC1
  and2) and proline-rich Akt substrate 40 (PRAS40). The PI3K/AKT/mTOR signaling pathway
  exhibits cross-talk with the RAS/MAPK pathway.Abbreviations: BAD, Bcl-2 associated
  agonist of cell death; EGFR. Epidermal growth factor receptor; FOXO, forkhead box
  protein O1; IGFR, insulin-like growth factor receptor; GSK3b,glycogen synthase kinase-3;
  mTOR, mechanistic target of rapamycin; mTORC, mTOR complex; PDGFR, platelet-derived
  growth factor receptor; PDK1, protein serine/threonine kinase-3′-phosphoinositide-dependent
  kinase 1; PI3K, phosphoinositide 3-kinase; PIP2, phosphatidylinositol 4,5-bisphosphate;
  PIP3, phosphatidylinositol (3,4,5)-triphosphate; PTEN, phosphatase and tensin homolog;
  RTK, receptor tyrosine kinase; TSC, tuberous sclerosis complex; TTF1, Thyroid transcription
  factor 1; SGK1, serum and glucocorticoid regulated kinase 1; VEGFR, vascular endothelial
  growth factor receptor; 4EBP1, 4E binding protein 1.'
papertitle: Somatic Overgrowth Disorders of the PI3K/AKT/mTOR Pathway & Therapeutic
  Strategies.
reftext: Kim M. Keppler-Noreuil, et al. Am J Med Genet C Semin Med Genet. ;172(4):402-421.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8976264
figid_alias: PMC5592089__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
redirect_from: /figures/PMC5592089__F1
ndex: 74f4c728-df14-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5592089__nihms902445f1.html
  '@type': Dataset
  description: 'Diagram of the PI3K/AKT/mTOR pathway and interaction with PTEN and
    TSC1/TSC2. Potential sites of action of inhibitors are shown. PI3K converts PIP2
    into PIP3, which interacts with AKT at the cellular membrane where it is phosphorylated
    and activated. PTEN is a negative regulator of PI3K, which dephosphorylates PIP3.
    AKT serves a range of cellular functions with effects on metabolism and cell survival,
    and through indirect activation of mTOR controls cell proliferation, protein translation,
    and autophagy. mTOR exists as two multi-protein complexes, mTORC1 and mTORC2.
    mTORC2 lies upstream of and activates AKT, whereas mTORC1 lies downstream from
    AKT and is activated via AKT-mediated inhibition of tuberous sclerosis complex
    1 and 2 (TSC1 and2) and proline-rich Akt substrate 40 (PRAS40). The PI3K/AKT/mTOR
    signaling pathway exhibits cross-talk with the RAS/MAPK pathway.Abbreviations:
    BAD, Bcl-2 associated agonist of cell death; EGFR. Epidermal growth factor receptor;
    FOXO, forkhead box protein O1; IGFR, insulin-like growth factor receptor; GSK3b,glycogen
    synthase kinase-3; mTOR, mechanistic target of rapamycin; mTORC, mTOR complex;
    PDGFR, platelet-derived growth factor receptor; PDK1, protein serine/threonine
    kinase-3′-phosphoinositide-dependent kinase 1; PI3K, phosphoinositide 3-kinase;
    PIP2, phosphatidylinositol 4,5-bisphosphate; PIP3, phosphatidylinositol (3,4,5)-triphosphate;
    PTEN, phosphatase and tensin homolog; RTK, receptor tyrosine kinase; TSC, tuberous
    sclerosis complex; TTF1, Thyroid transcription factor 1; SGK1, serum and glucocorticoid
    regulated kinase 1; VEGFR, vascular endothelial growth factor receptor; 4EBP1,
    4E binding protein 1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - Pdgfrb
  - Pik3r1
  - pk
  - Ecm1
  - Ppp1r13b
  - Pik3ca
  - Pten
  - Mtor
  - ras
  - Hras
  - Kras
  - Rem1
  - Grb2
  - Braf
  - Irs1
  - Pdk1
  - Pdpk1
  - Mdk
  - Akt1
  - Bad
  - Ephb2
  - Mapk1
  - Tsc1
  - Slc12a3
  - Tsc22d1
  - Tsc2
  - Ttf1
  - Nkx2-1
  - Rheb
  - Rptor
  - Rps6kb1
  - tor
  - Rorc
  - Eif4ebp1
  - Pik3cg
  - Ccne1
  - Ephb1
  - EGFR
  - PDGFRB
  - PDGFRA
  - IGF1R
  - KDR
  - FLT1
  - FLT4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - CUX1
  - SART3
  - PTEN
  - MTOR
  - KRAS
  - HRAS
  - NRAS
  - GRB2
  - MAPKAP1
  - RICTOR
  - MLST8
  - BRAF
  - IRS1
  - PDK1
  - PDPK1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - BAD
  - EPHB2
  - MAPK1
  - MAPK3
  - TSC1
  - CCL26
  - SLC12A3
  - TESC
  - TSC2
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - RPTOR
  - TTF1
  - NKX2-1
  - RHEB
  - RHEBP1
  - RPS6KB1
  - RORC
  - EIF4EBP1
  - Glucose
  - Cancer
  - Lung cancer
---
